Page last updated: 2024-09-02

n(g)-iminoethylornithine and angiotensin ii, des-phe(8)-

n(g)-iminoethylornithine has been researched along with angiotensin ii, des-phe(8)- in 1 studies

Compound Research Comparison

Studies
(n(g)-iminoethylornithine)
Trials
(n(g)-iminoethylornithine)
Recent Studies (post-2010)
(n(g)-iminoethylornithine)
Studies
(angiotensin ii, des-phe(8)-)
Trials
(angiotensin ii, des-phe(8)-)
Recent Studies (post-2010) (angiotensin ii, des-phe(8)-)
1711361,53321995

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, L; Gao, Q; Jiang, T; Lu, J; Tan, L; Tan, MS; Wang, HF; Yu, JT; Zhang, QQ; Zhang, YD; Zhu, XC1

Other Studies

1 other study(ies) available for n(g)-iminoethylornithine and angiotensin ii, des-phe(8)-

ArticleYear
Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway.
    British journal of pharmacology, 2014, Volume: 171, Issue:18

    Topics: Angiogenesis Inhibitors; Angiotensin I; Angiotensin II; Animals; Brain; Cerebrovascular Circulation; Endostatins; Infarction, Middle Cerebral Artery; Male; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Ornithine; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled

2014